New Binaural Beats Meditation Program Now Available in iOS
Previous
RANDOM
V-Go a go! VLRX rides Type 2 diabetes patient adoption wave to 10 Millionth Device Sold
Next
Medecine

GSK to Present New Evolutions in Targeted RNA Drug Delivery Systems

SMi Reports: RNA Therapeutics 2017, 22nd & 23rd February, London, United Kingdom
Overview
Credits

EINPresswire.com

Press Contacts

Teri Arri
+44 (0)20 7827 6162
tarri@smi-online.co.uk

LONDON, ENGLAND, UNITED KINGDOM, November 17, 2016 SMi Group are thrilled to have Jeffrey Ulmer, Head of Preclinical Research & Development from GSK, present a keynote at RNA Therapeutics 2017 when it returns to Central London next February.

With a focus on mRNA vaccines, the talk will delve further into key topics surrounding immune responses, animal models, platform technology and rapid response to emerging infectious diseases.

In the run-up to his address, Dr Ulmer said:

“RNA therapeutics, including recent exciting advancements in RNA-based vaccines, have the potential to be game-changing technologies. This conference will bring together thought leaders from across the technology area…”

Now in its 8th year, the RNA event will aim to deliver a scientific toolkit of ideas to implement targeted delivery and mRNA. Attendees will not only learn about new academic research, but will also hear a selection of case studies from big pharma and bio-pharmaceutical companies currently making medical progress through RNA therapeutics.

Other notable speakers on the agenda include:

• Nagy Habib, Head of Surgery, Co-Founder, Imperial College Healthcare NHS Trust, MiNA Therapeutics
• Heinrich Haas, Vice President RNA Formulation & Drug Delivery, BioNTech RNA Pharmaceuticals
• Bo Rode Hansen, Global Head of RNA Therapeutics, Roche
• John Johnston, Clinical Assessor Biologicals & Biotechnology Unit, MHRA
• Nicole Meisner-Kober, Senior Investigator, RNA Biology, Novartis Institutes for Biomedical Research
• Steve Hood, Director, Bioimaging, GSK
• David Giljohann, CEO, Exicure
• Shai Erlich, Chief Medical Officer & President USA, Quark Pharmaceuticals Inc
• Amotz Shemi, CEO, Silenseed
• Sanyogitta Puri, Associate Principal Scientist, AstraZeneca

SMi’s 8th annual RNA Therapeutics conference will take place on 22nd & 23rd February 2017 at the Copthorne Tara Hotel in Kensington, London, UK.

Further information including a detailed agenda and full speaker line-up is available at www.therapeutics-rna.com

What's your reaction?
I Love It
100%
Cool
0%
It's OK
0%
What?
0%
I'm Sad
0%
I Hate It
0%

Leave a Response